Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Letter From The Editor Previous | All Articles This Week | Next
This article originally posted 21 October, 2011 and appeared in  Issue 596

Letter from the Editor #596: Time to Walk the Walk

How many of you can say you practice what you preach when it comes to food and exercise? How about your office staff, can you say that most of them exemplify the ideals that you promote to patients? Do you think that we have accepted unhealthy food choices, lack of exercise, and obesity as the norm? According to Dr. Sheri Colberg, PhD, we have. In this week's feature, A Culture of Obesity? Time to Walk the Walk, she discusses the findings of a 20 year study and how our perceptions of what's "normal" have changed over the years.

We often start our patients on basal insulin because they need extra help controlling their glucose and then we increase that basal insulin even though they need help with prandial glucose control. We know we should start them on mealtime insulin but the fear of hypoglycemia often causes us to postpone that decision. Now we have a way to address mealtime excursions without the fear of hypoglycemia as the FDA has approved the use of BYETTA® (exenatide) with Insulin Glargine. 

*****

Announcements:

TCOYD Conference and Health Fair, San Diego Convention Center, San Diego, California, Saturday, November 12, 2011

Join Steven Edelman, MD and Charlie Kimball, IZOD Indy Car Driver; Phil Southerland, Professional Cyclist, Founder, Team Type 1; and Ben Vereen, Singer, Dancer, and Actor, for a day focused on diabetes health and wellness.

dLife.com: October 23, 7PM ET on CNBC

Topics: dLife brings you the harrowing story of Ernest Sterzer, a type 1 teenager who survived the unthinkable in Nazi Germany. Also, a special tribute to the late, great sports legend, Ron Santo. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.

Please answer this week's poll: Have sulphonylureas become obsolete in your practice?

Vote in and then see results from previous polls here.

*****************************
We can make a difference!
*****************************

Check out this week's "Test Your Diabetes Knowledge" question!

Dave Joffe, Editor-in-chief

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 21 October, 2011 and appeared in  Issue 596

Past five issues: Issue 744 | Diabetes Clinical Mastery Series Issue 203 | Issue 743 | Diabetes Clinical Mastery Series Issue 202 | SGLT-2 Inhibitors Special Edition August 2014 |


Cast Your Vote
When Afrezza is available, will you prescribe it immediately or wait until it has been on the market for a while?
CME/CE of the Week
Category: Nutrition
Credits: .75
Search Articles On Diabetes In Control